Immediate Management of Diabetic Ketoacidosis (DKA)
The immediate management of DKA requires aggressive fluid resuscitation with isotonic saline, intravenous insulin therapy, potassium replacement, and identification of precipitating factors. 1
Initial Assessment and Diagnosis
Diagnostic criteria for DKA:
- Blood glucose >250 mg/dL
- Arterial pH <7.3
- Bicarbonate <15 mEq/L
- Moderate ketonuria or ketonemia
Immediate laboratory evaluation:
- Arterial blood gases
- Complete blood count with differential
- Blood glucose, BUN, electrolytes, creatinine
- Serum ketones
- Calculated anion gap and osmolality
- Urinalysis and urine ketones
- ECG
- Cultures (blood, urine, throat) if infection suspected
- Chest X-ray if indicated
Step-by-Step Management Protocol
1. Fluid Resuscitation (First Priority)
- Adults: Isotonic saline (0.9% NaCl) at 15-20 mL/kg/h (approximately 1-1.5 L) during the first hour 1
- Children: Isotonic saline (0.9% NaCl) at 10-20 mL/kg/h, not exceeding 50 mL/kg in first 4 hours 1
- Subsequent fluid choice:
- If corrected serum sodium is normal/elevated: 0.45% NaCl at 4-14 mL/kg/h
- If corrected serum sodium is low: continue 0.9% NaCl at similar rate
- Goal: Correct estimated deficits within 24 hours for adults, 48 hours for children
2. Insulin Therapy (Begin after initial fluid resuscitation)
- Start 1-2 hours after beginning fluid therapy
- Intravenous regular insulin:
- Initial bolus: 0.15 U/kg body weight
- Continuous infusion: 0.1 U/kg/h (typically 5-7 U/h in adults) 1
- Continue until ketoacidosis resolves (pH >7.3, bicarbonate >15 mEq/L)
- When glucose reaches 250 mg/dL, add dextrose to IV fluids (5% dextrose in 0.45% saline)
3. Potassium Replacement
- Only after confirming adequate renal function and serum K+ is known
- If initial K+ is <3.3 mEq/L: Give potassium before starting insulin
- Add 20-30 mEq/L potassium (2/3 KCl and 1/3 KPO₄) to IV fluids 1
- Goal: Maintain serum K+ between 4-5 mEq/L
4. Monitoring
- Vital signs: Every 1-2 hours
- Blood glucose: Every 1-2 hours until stable
- Electrolytes, BUN, creatinine: Every 2-4 hours initially
- Arterial pH and bicarbonate: Every 4-6 hours until normalized
- Neurological status: Hourly (especially in children to monitor for cerebral edema)
5. Identify and Treat Precipitating Factors
- Common precipitants:
- Infection (pneumonia, UTI, sepsis)
- Inadequate insulin (missed doses, pump failure)
- New-onset diabetes
- Myocardial infarction
- Stroke
- Medications (glucocorticoids, thiazides, sympathomimetics)
- Emotional stress
Special Considerations
Bicarbonate Therapy
- Not recommended in most cases of DKA 2
- May be considered only in extreme acidosis (pH <6.9) or if there is life-threatening hyperkalemia
Cerebral Edema Prevention (Critical in Pediatric Patients)
- Avoid rapid fluid administration
- Avoid rapid decreases in serum osmolality (should not exceed 3 mOsm/kg/h) 1
- Monitor neurological status frequently
- Risk factors: severe acidosis, greater hypocapnia, elevated BUN, bicarbonate treatment 3
Transition from IV to Subcutaneous Insulin
- Begin subcutaneous basal insulin 2-4 hours before discontinuing IV insulin 1
- Continue IV insulin until subcutaneous insulin takes effect to prevent rebound hyperglycemia
Common Pitfalls to Avoid
- Inadequate fluid resuscitation: Underestimating fluid deficits can delay recovery
- Premature insulin administration: Starting insulin before fluid resuscitation can worsen hypovolemia
- Inadequate potassium replacement: Can lead to life-threatening arrhythmias
- Failure to identify precipitating factors: Can lead to recurrent DKA
- Bicarbonate administration: Generally not beneficial and may increase risk of cerebral edema
- Overly rapid correction of hyperglycemia: Target glucose reduction of 50-75 mg/dL/h to avoid rapid osmolality changes
- Neglecting to monitor for hypoglycemia: When adding dextrose to IV fluids, continue insulin to clear ketones
By following this structured approach to DKA management with careful attention to fluid resuscitation, insulin therapy, electrolyte replacement, and monitoring, mortality and morbidity can be significantly reduced 1.